Gypenoside XLIX ameliorates diabetic retinopathy by downregulating prostaglandin-endoperoxide synthase 2 in retinal pigment epithelium cells to inhibit ferroptosis and preserve tight junction integrity
- DOI
- 10.3389/fphar.2026.1777313
- Published
- 2026-03-23
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1777313,
title = {Gypenoside XLIX ameliorates diabetic retinopathy by downregulating prostaglandin-endoperoxide synthase 2 in retinal pigment epithelium cells to inhibit ferroptosis and preserve tight junction integrity},
author = {Jiayi Gu and Manhui Zhu and Lele Li and Xin Cao and Xiaoli Yu and Xiaobo Huang and Lili Huang and Qi Cai and Yan Zhu and Wendie Li and Yong Wang},
year = {2026},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2026.1777313},
url = {https://doi.org/10.3389/fphar.2026.1777313}
}RIS
TY - JOUR TI - Gypenoside XLIX ameliorates diabetic retinopathy by downregulating prostaglandin-endoperoxide synthase 2 in retinal pigment epithelium cells to inhibit ferroptosis and preserve tight junction integrity AU - Jiayi Gu AU - Manhui Zhu AU - Lele Li AU - Xin Cao AU - Xiaoli Yu AU - Xiaobo Huang AU - Lili Huang AU - Qi Cai AU - Yan Zhu AU - Wendie Li AU - Yong Wang PY - 2026 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2026.1777313 UR - https://doi.org/10.3389/fphar.2026.1777313 ER -
APA
Gu, J., Zhu, M., Li, L., Cao, X., Yu, X., Huang, X., Huang, L., Cai, Q., Zhu, Y., Li, W., & Wang, Y. (2026). Gypenoside XLIX ameliorates diabetic retinopathy by downregulating prostaglandin-endoperoxide synthase 2 in retinal pigment epithelium cells to inhibit ferroptosis and preserve tight junction integrity. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1777313
Source records
- crossref · retrieved 2026-09-27T03:40:19.018Z